logo

COYA

Coya Therapeutics·NASDAQ
--
--(--)
--
--(--)

COYA fundamentals

Coya Therapeutics (COYA) released its earnings on Aug 12, 2025: revenue was 163.62K (YoY -95.19%), missed estimates; EPS was -0.36 (YoY -89.47%), beat estimates.
Revenue / YoY
163.62K
-95.19%
EPS / YoY
-0.36
-89.47%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 11, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

COYA has released its 2025 Q4 earnings report, with revenue of 3.96M, reflecting a YoY change of 202768.80%, and net profit of -5.71M, showing a YoY change of -95.78%. The Sankey diagram below clearly presents COYA's revenue sources and cost distribution.

Key Indicators

Coya Therapeutics (COYA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Coya Therapeutics (COYA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Coya Therapeutics (COYA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Coya Therapeutics (COYA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Coya Therapeutics (COYA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Coya Therapeutics (COYA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield